Cancer Stem Cells Market is estimated to be US$ 4 billion by 2034; Growing Prevalence of Cancer Diseases to Fuel Market Growth

Published Date: March 2024

Stem Cells are the cells from which other types of cells with specialized functions are generated. Cancer Stem Cell studies help to understand root cause and understand how cancer disease occurs, they also help in treating people with lymphoma and leukemia.

Growing investment of major companies in stem cell project has fueled the market growth. New product launched, merger and acquisition of companies to expand its stem cell portfolio is expected to foster the demand for Cancer Stem Cells market growth in coming years.

The report Cancer Stem Cells Market, By Cancer Type (Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others), By Mode of Action (Targeted CSCs, Stem Cell based Cancer Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

  • In June 2021, Jasper Therapeutics Inc., and Amplitude Healthcare Acquisition Corporation has announced its merger acquisition to create Biotechnology Company in Hematopoietic Stem Cell Transplantation.

Analyst View:

The key factor driving the growth of the Cancer Stem Cells Market is growing prevalence of cancer diseases. Advantages of autologous transplant and improved survival rate of patients has further, enhanced the market growth. Technological advancement is expected to boost the demand for Cancer Stem Cells market growth in future. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on Cancer Stem Cells Market, By Cancer Type (Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others), By Mode of Action (Targeted CSCs, Stem Cell based Cancer Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Cancer Stem Cells Market accounted for US$ 1.4 billion in 2024 and is estimated to be US$ 4 billion by 2034 and is anticipated to register a CAGR of 1.50%. The Cancer Stem Cells Market is segmented based on Cancer Type, Mode of Action and Region.

  • Based on Cancer Type, Cancer Stem Cells Market is segmented into Blood Cancer, Breast Cancer, Bladder Cancer, Lung Cancer, Liver Cancer and Others.
  • Based on Mode of Action, Cancer Stem Cells Market is segmented into Targeted CSCs, Stem Cell based Cancer Therapy.
  • By Region, the Cancer Stem Cells Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Cancer Stem Cells Market:

The prominent players operating in the Cancer Stem Cells Market includes, AbbVie Inc., Thermo Fisher Scientific Inc., Merck KGaA, Stemline Therapeutics Inc., OncoMed Pharmaceuticals Inc., PromoCell GmbH, Miltenyi Biotec, Irvine Scientific, Sino Biological Inc., STEMCELL Technologies Inc., and others.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com

 

Buy Now
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Custmoized Your Report
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request for Discount
Reliability and Reputation

Quick contact

IND: +91 777 504 9802
US: +1 860 531 2574

Trusted By

Created billion dollars of revenue impact with more than 200+ clients

View All Our Clients